Quarterlytics / Industries / Healthcare / Biotechnology
Industry
Healthcare

Biotechnology

446 companies in this industry — from early-stage micro-caps to established names the market already covers.

446companies 30pages Healthcare
Companies covered 446
Sector Healthcare
Industry Biotechnology
Latest filing PHAT · 2024
Coverage Updated weekly
Exchange Sort
Showing 15 of 446 companies Page 12 of 30
PHAT NASDAQ · 427 emp.

Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases...

OMER NASDAQ · 202 emp.

Omeros Corporation

Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan...

GERN NASDAQ · 229 emp.

Geron Corporation

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic ...

BPMUF OTC · 164 emp.

Basilea Pharmaceutica AG

Basilea Pharmaceutica AG, a commercial stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeu...

Biotechnology
PHARM.AS AMS · 404 emp.

Pharming Group N.V.

Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare ...

Biotechnology
TBPH NASDAQ · 97 emp.

Theravance Biopharma, Inc.

Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia...

ETON NASDAQ · 31 emp.

Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The comp...

ORIC NASDAQ · 122 emp.

ORIC Pharmaceuticals, Inc.

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its c...

Biotechnology
XNCR NASDAQ · 250 emp.

Xencor, Inc.

Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutic...

SPRY NASDAQ · 155 emp.

ARS Pharmaceuticals, Inc.

ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe a...

Biotechnology
ABUS NASDAQ · 44 emp.

Arbutus Biopharma Corporation

Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other ...

PHGUF OTC · 404 emp.

Pharming Group N.V.

Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare ...

Biotechnology
KURA NASDAQ · 192 emp.

Kura Oncology, Inc.

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline ...

PHAR NASDAQ · 404 emp.

Pharming Group N.V.

Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare ...

PPTDF OTC · 621 emp.

PeptiDream Inc.

PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate t...

Biotechnology
1 11 12 13 30
Healthcare · Biotechnology coverage

The whole industry,
in one read.

We publish original research across all biotechnology companies — profiles, earnings reports and news on the small- and mid-caps the market overlooks. 446 companies, permanently indexed. Free to read.

All Healthcare companies Browse all industries →
Editorial photograph